NOBILI, ELISABETTA
NOBILI, ELISABETTA
DIPARTIMENTO DI EMATOLOGIA E SCIENZE ONCOLOGICHE "L. e A. SERAGNOLI"
NOBILI E.; E. NOBILI
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor.
2018 Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E, Ardizzoni A, Massari F
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment?
2009 Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G.
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment?
2009 Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G.
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid
2008 Nobili E.; Pezzilli R.; Santini D.; Campidelli C.; Calculli L.; Casadei R.; Biasco G.
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study.
2014 Berruti A;Fazio N;Ferrero A;Brizzi MP;Volante M;Nobili E;Tozzi L;Bodei L;Torta M;D Avolio A;Priola AM;Birocco N;Amoroso V;Biasco G;Papotti M;Dogliotti L
Breast carcinoma presenting as linitis plastica
2010 Brandi G; Campadelli E; Nobili E; Leone O
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean
2008 G. Brandi;R Di Cicilia;M.Di Battista;E.Nobili;M.Astorino;M. Di Marco;MA Pantaleo;G.Biasco
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis.
2004 BIASCO G.; CENACCHI G; NOBILI E; PANTALEO MA; CALABRESE C; DI FEBO G; MORSELLI LABATE A; MIGLIOLI M; BRANDI G.
Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma.
2018 Vincenzo Di Nunno; Veronica Mollica; Beniamino Corcioni; Michelangelo Fiorentino; Elisabetta Nobili; Riccardo Schiavina; Rita Golfieri; Eugenio Brunocilla; Andrea Ardizzoni; Francesco Massari
Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report
2021 Filippini D.M.; Di Federico A.; Lenzi B.; Nobili E.; Brocchi S.; Malvi D.; Brandi G.
Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients
2016 P Ghedini, I Bossert, T Graziani, F Ceci, F Massari, E Nobili, B Melotti, P Castellucci, S Fanti, C Nanni
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC)
2009 Brandi, Giovanni; Paterini, Paola; Tavolari, Simona; dal Pozzo, G.; Nobili, Elisabetta; DI CICILIA, Roberto; DI MARCO, Mariacristina; Pantaleo, MARIA ABBONDANZA; DE ROSA, Francesco; Biasco, Guido
EXOCRINE-ENDOCRINE PANCREATIC CANCER AND alpha-FETOPROTEIN
2008 G. BRANDI;E. NOBILI; E.CAPIZZI;B. CORTI; R. DI CICILIA; M. DI MARCO;G. BIASCO
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE
2008 M.Di Marco ;M. Macchini; R. Di Cicilia ; E. Nobili ; G. Biasco
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOISTITUTIONAL EXPERIENCE.
2007 Di Marco M; Nobili E; Di Cicilia R; Brandi G; Bertolini S; Derenzini E; Dell’Arte S; Casadei R; Calculli L; Biasco G.
Gemox in combination witherlotinib (E) in pancreatic cancer (PC).
2008 R. Di Cicilia;M. Macchini; M. Di Marco;E. Nobili;L.Calculli;R. Casadei; G.Biasco
High prevalence of asbestos exposure in bile duct cancer patients
2010 S. Di Girolamo; F. de Rosa; E. Nobili; V. Agostini; J. Corbelli; G. Biasco; G. Brandi
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?
2020 Di Federico A.; Nuvola G.; Sisi M.; Lenzi B.; Nobili E.; Campana D.
Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma.
2011 S. Di Girolamo; E. Nobili; E. Derenzini; F. de Rosa; V. Agostini; G. Ercolani; J. Corbelli; A. Pinna; G. Biasco; G. Brandi
IMPACT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL OF PATIENTS WITH KLATSKIN TUMOR
2009 S. Di Girolamo; V. Agostini; E. Nobili; F. De Rosa; GL. Grazi; G. Ercolani; R. Golfieri; M. Fiorentino; E. Derenzini; G. Biasco; G. Brandi
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. | Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E,... Ardizzoni A, Massari F | 2018-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? | Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G. | 2009-01-01 | ANNALS OF ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? | Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G. | 2009-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid | Nobili E.; Pezzilli R.; Santini D.; Campidelli C.; Calculli L.; Casadei R.; Biasco G. | 2008-01-01 | CASE REPORTS IN GASTROENTEROLOGY | - | 1.01 Articolo in rivista | crg0002-0011.pdf |
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. | Berruti A;Fazio N;Ferrero A;Brizzi MP;Volante M;Nobili E;Tozzi L;Bodei L;Torta M;D Avolio A;Priol...a AM;Birocco N;Amoroso V;Biasco G;Papotti M;Dogliotti L | 2014-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | 1471-2407-14-184.pdf |
Breast carcinoma presenting as linitis plastica | Brandi G; Campadelli E; Nobili E; Leone O | 2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean | G. Brandi;R Di Cicilia;M.Di Battista;E.Nobili;M.Astorino;M. Di Marco;MA Pantaleo;G.Biasco | 2008-01-01 | ANNALS OF ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. | BIASCO G.; CENACCHI G; NOBILI E; PANTALEO MA; CALABRESE C; DI FEBO G; MORSELLI LABATE A; MIGLIOLI... M; BRANDI G. | 2004-01-01 | HUMAN PATHOLOGY | - | 1.01 Articolo in rivista | - |
Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma. | Vincenzo Di Nunno; Veronica Mollica; Beniamino Corcioni; Michelangelo Fiorentino; Elisabetta Nobi...li; Riccardo Schiavina; Rita Golfieri; Eugenio Brunocilla; Andrea Ardizzoni; Francesco Massari | 2018-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report | Filippini D.M.; Di Federico A.; Lenzi B.; Nobili E.; Brocchi S.; Malvi D.; Brandi G. | 2021-01-01 | ANNALS OF PALLIATIVE MEDICINE | - | 1.01 Articolo in rivista | Critical diagnostic delay.pdf |
Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients | P Ghedini, I Bossert, T Graziani, F Ceci, F Massari, E Nobili, B Melotti, P Castellucci, S Fanti,... C Nanni | 2016-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 4.02 Riassunto (Abstract) | - |
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) | Brandi, Giovanni; Paterini, Paola; Tavolari, Simona; dal Pozzo, G.; Nobili, Elisabetta; DI CICILI...A, Roberto; DI MARCO, Mariacristina; Pantaleo, MARIA ABBONDANZA; DE ROSA, Francesco; Biasco, Guido | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
EXOCRINE-ENDOCRINE PANCREATIC CANCER AND alpha-FETOPROTEIN | G. BRANDI;E. NOBILI; E.CAPIZZI;B. CORTI; R. DI CICILIA; M. DI MARCO;G. BIASCO | 2008-01-01 | PANCREAS | - | 1.01 Articolo in rivista | - |
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE | M.Di Marco ;M. Macchini; R. Di Cicilia ; E. Nobili ; G. Biasco | 2008-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOISTITUTIONAL EXPERIENCE. | Di Marco M; Nobili E; Di Cicilia R; Brandi G; Bertolini S; Derenzini E; Dell’Arte S; Casadei R; C...alculli L; Biasco G. | 2007-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). | R. Di Cicilia;M. Macchini; M. Di Marco;E. Nobili;L.Calculli;R. Casadei; G.Biasco | 2008-01-01 | JOP. JOURNAL OF THE PANCREAS | s.n | 4.02 Riassunto (Abstract) | - |
High prevalence of asbestos exposure in bile duct cancer patients | S. Di Girolamo; F. de Rosa; E. Nobili; V. Agostini; J. Corbelli; G. Biasco; G. Brandi | 2010-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? | Di Federico A.; Nuvola G.; Sisi M.; Lenzi B.; Nobili E.; Campana D. | 2020-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma. | S. Di Girolamo; E. Nobili; E. Derenzini; F. de Rosa; V. Agostini; G. Ercolani; J. Corbelli; A. Pi...nna; G. Biasco; G. Brandi | 2011-01-01 | - | - | 4.03 Poster | - |
IMPACT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL OF PATIENTS WITH KLATSKIN TUMOR | S. Di Girolamo; V. Agostini; E. Nobili; F. De Rosa; GL. Grazi; G. Ercolani; R. Golfieri; M. Fiore...ntino; E. Derenzini; G. Biasco; G. Brandi | 2009-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |